Author/Authors :
شاپور، اميدواري نويسنده Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran Omidvari, Shapour , نصرالهي، حميد نويسنده Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran Nasrolahi, Hamid , مودب شعار، ليلا نويسنده Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran MoaddabShoar, Leila , حامدي، سيد حسن نويسنده Student Research Committee, Resident of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran Hamedi, Sayed Hasan , محمديان پناه، محمد نويسنده , , دانشبد، يحيي نويسنده Dr. Daneshbod Pathology Laboratory, Shiraz, IR Iran Daneshbod, Yahya , منصور، انصاري نويسنده Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran Ansari, Mansour , احمدلو، نيلوفر نويسنده , , مصلايي ، احمد نويسنده ,
Abstract :
Introduction: Mucosa-associated lymphoid tissue (MALT) lymphoma most commonly involves the stomach and its treatment is surgery, antibiotic therapy or radiotherapy. Rectal MALT is not only so rare, but also the treatment is not clear as gastric MALT.
Case Presentation: Our patient was a 66 year-old man presenting with 5-6 months abdominal pain and anemia. In colonoscopy, a rectal ulcer was found and biopsy revealed MALT lymphoma. Physical examination and staging evaluations had normal results. Radiotherapy was started for him but he did not tolerate radiotherapy and instead received chemotherapy. After 38 months of follow up, he was fine.
Conclusions: The incidence of rectal MALT is rare, and treatment is not so clear. The results on H. pylori eradication, radiotherapy and chemotherapy are more controversial.
